Evidence map›Paper›PMID 41390840›Full record

ArticleNPJ digital medicine2025

Deep learning-enabled accurate assessment of gait impairments in Parkinson's disease using smartphone videos.

Jianda Han, Zhihua Tian, Jialing Wu, Kai Zhang, Shaohua Li, Fahd Baig, Peipei Liu, Ravi Vaidyanathan, Francesca Morgante, Weiguang Huo

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jianda Han *College of Artificial Intelligence, Nankai University, Tianjin, China.
Zhihua Tian *College of Artificial Intelligence, Nankai University, Tianjin, China.
Jialing Wu *Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.
Kai ZhangCollege of Artificial Intelligence, Nankai University, Tianjin, China.
Shaohua LiCollege of Artificial Intelligence, Nankai University, Tianjin, China.
Fahd BaigNeurosciences and Cell Biology Institute, Neuromodulation and Motor Control Section, City St George's University of London, London, UK.
Peipei LiuDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin, China.
Ravi VaidyanathanDepartment of Mechanical Engineering, Imperial College London, London, UK.
Francesca MorganteNeurosciences and Cell Biology Institute, Neuromodulation and Motor Control Section, City St George's University of London, London, UK.
Weiguang HuoCollege of Artificial Intelligence, Nankai University, Tianjin, China. weiguang.huo@nankai.edu.cn.

Funding

National Key Research and Development Program of China 2022YFB4700200National Natural Science Foundation of China 62373202Tianjin Municipal Science and Technology Program 23JCYBJC01200
6 · The paper itself

Abstract

Gait impairments are among the most prevalent and disabling symptoms in Parkinson's Disease (PD), featuring complex and highly heterogeneous manifestations. Here, we propose a deep learning-based framework to assess gait impairments using smartphone-recorded videos. This framework demonstrated high proficiency in predicting PD severity, with a micro-average area under the receiver operating characteristic curve (AUC) of 0.87 and an F1 score of 0.806, comparable to the average performance of three clinical specialists. Additionally, it effectively discerned the comprehensive efficacy of medications on gait impairments with a precision of 73.68%. In particular, it demonstrated the ability to discriminate medication-induced fine-granular gait changes beyond the resolution of the Unified Parkinson's Disease Rating Scale (UPDRS). Furthermore, our interpretable framework enabled the extraction of traditional clinically used motion markers and the discovery of novel digital biomarkers sensitive to disease progression and medication response. The findings underscore its great potential for efficiently assessing disease progression in both clinical and home settings, as well as evaluating disease-modifying effects in clinical trials to promote personalized therapies.

Identifiers

PMID41390840
PMCPMC12855914

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.